Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy: The MOMPOD Randomized Clinical Trial

Kim A. Boggess, Arielle Valint, Jerrie S. Refuerzo, Noelia Zork, Ashley N. Battarbee, Kacey Eichelberger, Gladys A. Ramos, Gayle Olson, Celeste Durnwald, Mark B. Landon, Kjersti M. Aagaard, Kedra Wallace, Christina Scifres, Todd Rosen, Wadia Mulla, Amy Valent, Sherri Longo, Laura Young, M. Alison Marquis, Sonia ThomasAshley Britt, Diane Berry

Research output: Contribution to journalArticlepeer-review

Abstract

Preexisting type 2 diabetes in pregnant people increases the risk for adverse pregnancy outcomes, intrapartum complications, and neonatal hypoglycemia at birth. To achieve normal maternal glucose levels and optimize pregnancy outcomes, management includes maternal blood glucose monitoring, dietary management, and insulin therapy.

Original languageEnglish
Pages (from-to)322-324
Number of pages3
JournalObstetrical and Gynecological Survey
Volume79
Issue number6
DOIs
StatePublished - 1 Jun 2024
Externally publishedYes

Fingerprint

Dive into the research topics of 'Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy: The MOMPOD Randomized Clinical Trial'. Together they form a unique fingerprint.

Cite this